Literature DB >> 6313357

Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid.

A M Emmerson, D A Cox, L J Lees.   

Abstract

Eight volunteers each received lg of probenecid followed immediately by 1.5 g sultamicillin, both given by the oral route. Plasma concentrations of ampicillin and sulbactam were measured using a differential bioassay method. An ampicillin mean peak plasma concentration of 23.1 mg/l was found typically 1.5 h after dosing; the mean peak plasma concentration of sulbactam (10.0 mg/l) occurred at the same time. The mean plasma half-life of ampicillin was 1.45 h and that of sulbactam 1.3 h. The mean urinary recovery of ampicillin was 65% and that of sulbactam 62%. Five of the volunteers reported minor changes in bowel habits.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313357     DOI: 10.1007/bf02019464

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  12 in total

1.  Apparent effect of probenecid on the distribution of penicillins in man.

Authors:  M Gibaldi; M A Schwartz
Journal:  Clin Pharmacol Ther       Date:  1968 May-Jun       Impact factor: 6.875

2.  Emergence in the Netherlands of penicillinase-producing gonococci carrying "Africa" plasmid in combination with transfer plasmid.

Authors:  J D van Embden; B van Klingeren; M Dessens-Kroon; L J van Wijngaarden
Journal:  Lancet       Date:  1981-04-25       Impact factor: 79.321

3.  Combination of sulbactam pivoxyl and bacampicillin in acute exacerbations of chronic bronchitis.

Authors:  B I Davies; F P Maesen; S Jevons; J Brouwers
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

4.  A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin.

Authors:  S Hartley; R Wise
Journal:  J Antimicrob Chemother       Date:  1982-07       Impact factor: 5.790

5.  Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980.

Authors:  H W Jaffe; J W Biddle; S R Johnson; P J Wiesner
Journal:  J Infect Dis       Date:  1981-08       Impact factor: 5.226

6.  Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission.

Authors:  J A McCutchan; M W Adler; J R Berrie
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

7.  The combination of clavulanic acid and amoxycillin (Augmentin) in the treatment of patients infected with penicillinase producing gonococci.

Authors:  G A De Koning; D Tio; J F Coster; R A Coutinho; M C Ansink-Schipper
Journal:  J Antimicrob Chemother       Date:  1981-07       Impact factor: 5.790

8.  Clinical pharmacology of pivampicillin.

Authors:  K Roholt; B Nielsen; E Kristensen
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

9.  Comparative study of bacampicillin and ampicillin in the treatment of uncomplicated gonorrhoea.

Authors:  P J Spengler; L D Edwards
Journal:  Br J Vener Dis       Date:  1980-06

10.  Sultamicillin in the treatment of gonorrhoea caused by penicillin sensitive and penicillinase producing strains of Neisseria gonorrhoeae.

Authors:  W A Atia; A M Emmerson; D Holmes
Journal:  Br J Vener Dis       Date:  1983-10
View more
  2 in total

Review 1.  Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  H A Friedel; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

2.  Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers.

Authors:  B Hampel; H Lode; G Bruckner; P Koeppe
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.